[1]
S. Mugoša, Z. Džamić, M. Šahman-Zaimović, and N. Lukovac-Janjić, “Adverse drug reactions associated with sunitinib therapy: characteristics and risk factors”, Vojnosanit Pregl, vol. 78, no. 4, May 2021, doi: 10.2298/VSP201109145M.